Cadence Bank Genmab A/S Transaction History

Cadence Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $161,435 - $206,970	-5,216 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $171,502 - $232,477	5,216 New	5,216 $213,000
Q1 2021 May 11, 2021	SELL	$30.92 - $44.4 $161,278 - $231,590	-5,216 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$33.66 - $40.76 $175,570 - $212,604	5,216 New	5,216 $212,000

238

48.6M

6.8K

27.6K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $15.2B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

Stay updated on Cadence Bank with notifications on news.